Core--Clinical evaluation
核心--临床评价
基本信息
- 批准号:6643687
- 负责人:
- 金额:$ 17.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-01 至 2003-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Clinical Evaluation Core's goals are to: (1) recruit, characterize, and
follow all human subjects participating in projects #2-7 of the CCNMD
(2) develop and maintain state-of-the-art methods for clinical
characterization of human framework for testing the stress-diathesis
model of suicidal behavior. The CEC identified and recruits patients with
MDE, BPD, and Schizophrenia across the life cycle (and post-mortem).
Normal volunteers are recruited to provide normative values on the
clinical and neurobiological measures used and to establish psychometric
properties of measures in a non-pathological population. The CEC utilizes
a core of clinical/neuropsychological instruments covering major risk
factor domains for suicidal behavior, and ensures uniformity of
assessment domains and measures across the projects of the CCNMD.
These assessments include Axis I and II diagnostic interviews, measures
of state and trait-related risk factors, neuropsychological assessment,
measures of suicidal behavior, demographic history, life events, social
functioning, family psychiatric history. Assessments are performed at
intake, at time of biological procedures, at discharge, at 3 month, 1 and 2
year follow-up. The CEC investigates, develops and tests new assessment
procedures to address current and future needs in the field of suicide
research, and regularly reviews the reliability and validity of instruments.
The CEC ensures the quality of clinical assessments through inter-rater
reliability rounds using live or taped interviews. On all measures, our
faculty provides consultation to investigators in research methodology
and result interpretation. The CEC faculty provides consultation to
investigators in research methodology and result interpretation. The CEC
has successfully recruited and followed adequate members of life subjects
in the proposed diagnostic and age categories. The training and reliability
of all CCNMD raters is coordinated by the CEC. The CEC works with
SCC staff in developing forms, data management procedures and in
generating reliability statistics The CEC coordinates with the BIC
regarding recruitment, interviewing, control matching and subject flow.
The CEC obtains the blood and cerebrospinal fluid from subjects to be
analyzed by the CLC. The CEC interfaces with the Administrative Core
regarding recruitment of new staff and maintenance of a central database
of all CEC manuscripts. The CEC coordinates all diagnostic consensus
conferences.
临床评估核心的目标是:(1) 招募、表征和
关注参与 CCNMD 项目 #2-7 的所有人类受试者
(2) 开发和维护最先进的临床方法
用于测试压力素质的人体框架的表征
自杀行为模型。 CEC 确定并招募患有以下疾病的患者:
MDE、BPD 和精神分裂症贯穿整个生命周期(和死后)。
招募普通志愿者来提供关于
使用临床和神经生物学措施并建立心理测量学
非病态人群的测量特性。 CEC 利用
涵盖主要风险的临床/神经心理学核心工具
自杀行为的因素域,并确保自杀行为的一致性
CCNMD 各个项目的评估领域和措施。
这些评估包括轴 I 和轴 II 诊断访谈、措施
状态和特质相关的危险因素、神经心理学评估、
自杀行为、人口历史、生活事件、社会
功能正常,家族精神病史。评估进行于
摄入量、生物手术时、出院时、第 3 个月、第 1 个月和第 2 个月
年随访。 CEC 调查、开发和测试新评估
解决自杀领域当前和未来需求的程序
研究,并定期审查仪器的可靠性和有效性。
CEC 通过评估者间确保临床评估的质量
使用现场或录音采访进行可靠性调查。在所有措施上,我们
教师为研究人员提供研究方法方面的咨询
和结果解释。 CEC教师提供咨询
研究方法和结果解释的研究者。中委会
已成功招募并跟踪足够的生活受试者成员
在建议的诊断和年龄类别中。培训和可靠性
所有 CCNMD 评估者的评估均由 CEC 协调。 CEC 与
SCC 员工负责开发表格、数据管理程序和
生成可靠性统计数据 CEC 与 BIC 协调
关于招聘、面试、控制匹配和主题流程。
CEC从受试者身上获取血液和脑脊液
由 CLC 分析。 CEC 与管理核心接口
关于招聘新工作人员和维护中央数据库
所有 CEC 手稿。 CEC 协调所有诊断共识
会议。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAROLD A. SACKEIM其他文献
HAROLD A. SACKEIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAROLD A. SACKEIM', 18)}}的其他基金
CEREBROVASCULAR ABNORMALITIES IN LATE ONSET DEPRESSION
迟发性抑郁症的脑血管异常
- 批准号:
6343721 - 财政年份:1997
- 资助金额:
$ 17.72万 - 项目类别:
CEREBROVASCULAR ABNORMALITIES IN LATE ONSET DEPRESSION
迟发性抑郁症的脑血管异常
- 批准号:
2034705 - 财政年份:1997
- 资助金额:
$ 17.72万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 17.72万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 17.72万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 17.72万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 17.72万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 17.72万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 17.72万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 17.72万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 17.72万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 17.72万 - 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
- 批准号:
10762827 - 财政年份:2023
- 资助金额:
$ 17.72万 - 项目类别:














{{item.name}}会员




